TaiMed Biologics Inc. (4147.TWO)
TWD 82.5
(-0.48%)
TWD 82.5
(-0.48%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.26 Billion TWD | -8.46% |
| 2022 | 1.38 Billion TWD | 18.32% |
| 2021 | 1.16 Billion TWD | -7.25% |
| 2020 | 1.25 Billion TWD | 43.78% |
| 2019 | 876.03 Million TWD | 130.2% |
| 2018 | 380.55 Million TWD | 3470.99% |
| 2017 | -11.28 Million TWD | -122.97% |
| 2016 | -5.06 Million TWD | 10.06% |
| 2015 | -5.62 Million TWD | 0.0% |
| 2014 | - TWD | 0.0% |
| 2013 | - TWD | 0.0% |
| 2012 | - TWD | 0.0% |
| 2011 | - TWD | 0.0% |
| 2010 | - TWD | 0.0% |
| 2009 | - TWD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.21 Billion TWD | -3.69% |
| 2024 Q2 | 1.16 Billion TWD | -4.14% |
| 2023 Q4 | 1.26 Billion TWD | -6.04% |
| 2023 Q1 | 1.37 Billion TWD | -0.62% |
| 2023 FY | 1.26 Billion TWD | -8.46% |
| 2023 Q3 | 1.34 Billion TWD | -0.22% |
| 2023 Q2 | 1.34 Billion TWD | -1.75% |
| 2022 Q2 | 1.47 Billion TWD | -2.2% |
| 2022 Q1 | 1.5 Billion TWD | 28.88% |
| 2022 FY | 1.38 Billion TWD | 18.32% |
| 2022 Q4 | 1.38 Billion TWD | -7.77% |
| 2022 Q3 | 1.49 Billion TWD | 1.78% |
| 2021 Q4 | 1.16 Billion TWD | 1.16% |
| 2021 Q2 | 1.17 Billion TWD | -6.13% |
| 2021 Q1 | 1.25 Billion TWD | -0.59% |
| 2021 Q3 | 1.15 Billion TWD | -1.75% |
| 2021 FY | 1.16 Billion TWD | -7.25% |
| 2020 Q3 | 1.15 Billion TWD | 10.78% |
| 2020 FY | 1.25 Billion TWD | 43.78% |
| 2020 Q1 | 1.01 Billion TWD | 15.86% |
| 2020 Q2 | 1.03 Billion TWD | 2.32% |
| 2020 Q4 | 1.25 Billion TWD | 9.49% |
| 2019 Q4 | 876.03 Million TWD | 30.67% |
| 2019 FY | 876.03 Million TWD | 130.2% |
| 2019 Q1 | 329.45 Million TWD | -13.43% |
| 2019 Q2 | 660.56 Million TWD | 100.51% |
| 2019 Q3 | 670.39 Million TWD | 1.49% |
| 2018 FY | 380.55 Million TWD | 3470.99% |
| 2018 Q4 | 380.55 Million TWD | 71.63% |
| 2018 Q3 | 221.73 Million TWD | 2.89% |
| 2018 Q2 | 215.51 Million TWD | 18.36% |
| 2018 Q1 | 182.09 Million TWD | 0.0% |
| 2017 FY | -11.28 Million TWD | -122.97% |
| 2017 Q4 | - TWD | 0.0% |
| 2017 Q3 | - TWD | 0.0% |
| 2017 Q2 | - TWD | 0.0% |
| 2017 Q1 | - TWD | 0.0% |
| 2016 Q3 | - TWD | 0.0% |
| 2016 Q1 | - TWD | 0.0% |
| 2016 FY | -5.06 Million TWD | 10.06% |
| 2016 Q4 | - TWD | 0.0% |
| 2016 Q2 | - TWD | 0.0% |
| 2015 Q3 | - TWD | -100.0% |
| 2015 FY | -5.62 Million TWD | 0.0% |
| 2015 Q4 | - TWD | 0.0% |
| 2015 Q2 | 1.00 TWD | 0.0% |
| 2015 Q1 | - TWD | 0.0% |
| 2014 Q2 | - TWD | 0.0% |
| 2014 Q4 | - TWD | 0.0% |
| 2014 Q1 | - TWD | 0.0% |
| 2014 FY | - TWD | 0.0% |
| 2013 Q1 | - TWD | 0.0% |
| 2013 Q2 | 1.75 Million TWD | 0.0% |
| 2013 Q3 | - TWD | -100.0% |
| 2013 Q4 | - TWD | 0.0% |
| 2013 FY | - TWD | 0.0% |
| 2012 Q3 | - TWD | 0.0% |
| 2012 Q2 | - TWD | 0.0% |
| 2012 Q4 | - TWD | 0.0% |
| 2012 FY | - TWD | 0.0% |
| 2011 FY | - TWD | 0.0% |
| 2011 Q2 | - TWD | 0.0% |
| 2011 Q4 | - TWD | 0.0% |
| 2010 Q4 | - TWD | 0.0% |
| 2010 FY | - TWD | 0.0% |
| 2009 FY | - TWD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 1.23 Million TWD | -102095.719% |
| Genomics BioSci & Tech. Co.,Ltd. | 61.5 Million TWD | -1956.907% |
| Advagene Biopharma Co., Ltd. | -91.99 Thousand TWD | 1375313.861% |
| Taiwan Bio Therapeutics Co., Ltd | 40.96 Million TWD | -2988.524% |
| NaviFUS Corp. | 6.87 Million TWD | -18308.017% |
| G&E Herbal Biotechnology Co., Ltd. | 22.9 Million TWD | -5423.852% |
| TaiRx, Inc. | 11 Thousand TWD | -11501563.636% |
| Sinew Pharma Inc. | -766 Thousand TWD | 165267.493% |
| Lin BioScience, Inc. | - TWD | -Infinity% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -4.78 Million TWD | 26518.522% |
| Lumosa Therapeutics Co., Ltd. | 103.91 Million TWD | -1117.552% |
| Anti-Microbial Savior BioteQ Co., Ltd | 505 Thousand TWD | -250431.287% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 459.97 Million TWD | -175.055% |
| AP Biosciences Inc | - TWD | -Infinity% |
| Sunmax Biotechnology Co., Ltd. | 93.67 Million TWD | -1250.681% |
| RBC Bioscience Corporation | 44.42 Million TWD | -2748.036% |
| Syngen Biotech Co.,Ltd. | 348.98 Million TWD | -262.53% |
| EirGenix Inc. | 680.63 Million TWD | -85.882% |
| Enimmune corporation | 15.7 Million TWD | -7957.977% |
| Lukas Biomedical Inc. | 36.72 Million TWD | -3345.018% |
| BRIM Biotechnology, Inc. | -6.23 Million TWD | 20381.869% |
| 3D Global Biotech Inc. | 3.59 Million TWD | -35092.851% |
| Mycenax Biotech Inc. | 112.32 Million TWD | -1026.349% |
| TCI GENE Inc. | 54.84 Million TWD | -2206.75% |
| SynCore Biotechnology Co.,Ltd | 3.12 Million TWD | -40411.784% |
| Oneness Biotech Co., Ltd. | 122.73 Million TWD | -930.808% |
| Eusol Biotech Co.,Ltd. | -8.1 Million TWD | 15715.687% |
| Feng Chi Biotech Corp. | 19.03 Million TWD | -6545.916% |
| NeoCore Technology Co., Ltd. | 66.38 Million TWD | -1805.941% |
| TWi Biotechnology, Inc. | -435 Thousand TWD | 290946.667% |
| Neith Corporation | 463 Thousand TWD | -273157.667% |
| Sunny Pharmtech Inc. | 97.03 Million TWD | -1203.788% |
| VBI | 10.03 Million TWD | -12507.703% |
| Ever Supreme Bio Technology Co., Ltd | 69.08 Million TWD | -1731.316% |
| GeneReach Biotechnology Corp. | 67.37 Million TWD | -1777.851% |
| Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
| CHO Pharma, Inc. | 1.00 TWD | -126518299900.0% |
| Andros Pharmaceuticals Co.,Ltd | 1.08 Million TWD | -116185.202% |
| MegaPro Biomedical Co., Ltd | 20.51 Million TWD | -6068.615% |
| Visgeneer Inc. | 49.07 Million TWD | -2478.165% |
| Greenyn Biotechnology Co., Ltd | 163.13 Million TWD | -675.539% |
| BioLASCO Taiwan Co., Ltd. | 32.52 Million TWD | -3789.998% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 12.16 Million TWD | -10297.625% |
| Sagittarius Life Science Corp | 31.54 Million TWD | -3911.233% |
| BioGend Therapeutics Co., Ltd. | 16.54 Million TWD | -7546.921% |
| GlycoNex Incorporation | 17.4 Million TWD | -7169.913% |
| Medigen Biotechnology Corp. | 546.9 Million TWD | -131.335% |
| Pharmosa Biopharm Inc. | 21.9 Million TWD | -5674.718% |
| PharmaEngine, Inc. | 15.9 Million TWD | -7856.625% |
| Intech Biopharm Corporation | 41.52 Million TWD | -2946.798% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.17 Million TWD | -5876.019% |
| BiOptic Inc. | 161.07 Million TWD | -685.477% |
| TaiGen Biopharmaceuticals Holdings Limited | 34.15 Million TWD | -3604.348% |
| Senhwa Biosciences, Inc. | - TWD | -Infinity% |
| NatureWise Biotech & Medicals Corporation | 82.5 Million TWD | -1433.555% |
| OBI Pharma, Inc. | 25.93 Million TWD | -4778.849% |
| Savior Lifetec Corporation | 860.04 Million TWD | -47.107% |
| Great Novel Therapeutics Biotech & Medicals | 6.16 Million TWD | -20435.351% |
| Level Biotechnology Inc. | 88.85 Million TWD | -1323.954% |
| Medigen Vaccine Biologics Corporation | 383.63 Million TWD | -229.788% |
| Meribank Biotech Co., Ltd | 6.9 Million TWD | -18217.403% |
| Acepodia, Inc. | 39.52 Million TWD | -3100.726% |
| Caliway Biopharmaceuticals Co., Ltd. | 1.02 Million TWD | -123573.803% |